Entacapone
Entacapone (Stalevo) is a medicine used with levodopa to manage Parkinson’s disease symptoms in adults. This page lists the one formulation available in the catalogue.
Key points
- Stalevo is the only formulation in this catalogue.
- Entacapone is a COMT inhibitor, a class of medicine that extends the effect of levodopa.
- Novartis is the originator company behind the product.
What is in each Stalevo tablet?
Each Stalevo tablet contains three active ingredients (entacapone, levodopa, and carbidopa) in the strengths 200 mg, 100 mg, and 25 mg respectively. It is indicated for the management of Parkinson’s Disease.
Is entacapone available on its own in this catalogue?
No. The single product listed in this Neurology catalogue is Stalevo, a combination tablet containing entacapone, levodopa, and carbidopa. Entacapone does not appear as a standalone ingredient in this catalogue.